abstract |
The present invention discloses an insulin agonist peptide that binds to insulinotropic, wherein the insulinotropic insulin conjugate has agonist activity at the insulin receptor and the corresponding insulinotropic receptor, and stimulates weight loss in the individual administering the compound . |